Public-Private-Partnerships in Drug Research and Development

Herausgegeben:Michel, Martin C.; Wieland, Heike A.

• Gebundenes Buch

Produktbeschreibung

Collaborative approaches are becoming a key driver in drug discovery and development. They come in many types and forms ranging from project-based collaborations and strategic alliances to large international consortia. The volume discusses various types of such collaboration including the specific uses, advantages, and challenges. Based on the nature of public-private partnerships, we present views and experiences from academia, industry, and public stakeholders.

Produktdetails

• Handbook of Experimental Pharmacology 286
• Verlag: Springer / Springer Nature Switzerland / Springer, Berlin
• Artikelnr. des Verlages: 978-3-031-75805-8
• Seitenzahl: 208
• Erscheinungstermin: 21. November 2024
• Englisch
• Abmessung: 241mm x 160mm x 17mm
• Gewicht: 464g
• ISBN-13: 9783031758058
• ISBN-10: 3031758056
• Artikelnr.: 71729416

Inhaltsangabe

Novel and proven models of Public Private and Public Private Partnerships in Healthcare An Update.- Project based Public private collaborations.- Collaborative Innovations in Childhood Cancer Therapies.- Reaching outer space and enabling the mRNA revolution a critical role of partnerships for successful drug and vaccine development.- The Alliance between the German Cancer Research Center and Bayer a retrospective of an innovative collaboration model.- Life Science Incubation at LabCentral BioLabs with Partners Extending from the US to Europe.- Innovation at the Interface between Academia and Industry The BioMed X Model.- From innovator result driven to multi actor impact oriented Public Private Partnerships Integrating the patient perspective.- The Legal Framework for PPP in Drug R&D.